Chinese Medical Sciences Journal ›› 2011, Vol. 26 ›› Issue (3): 158-162.doi: 10.1016/S1001-9294(11)60041-2

• Original Article • Previous Articles     Next Articles

Serum HIF-1α and VEGF Levels Pre- and Post-TACE in Patients with Primary Liver Cancer

Zhong-zhi Jia1*, Guo-min Jiang1, Yao-liang Feng2   

  1. 1Department of Interventional Radiography, Changzhou Second People’s Hospital Affiliated to Nanjing Medical University, Changzhou 213003, China 2Department of Interventional Radiography, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
  • Online:2011-09-24 Published:2011-09-24

Abstract: Objective To investigate the expression levels of serum hypoxia inducible factor 1 alpha (HIF-1α) and vascular endothelial growth factor (VEGF) pre- and post-transcatheter arterial chemoembolization (TACE) in patients with primary liver cancer (PLC), and correlations between prognosis factors and serum HIF-1α as well as VEGF levels.
 Methods Forty consecutive patients fulfilling diagnostic criteria for PLC undergoing TACE from March 2008 to May 2009 were enrolled into the study. The serum HIF-1α and VEGF levels of PLC patients pre- and 1 day, 1 week, 1 month post-TACE were analyzed using ELISA, and compared with that of 20 healthy volunteers. Patients were divided into complete response (CR) and partial response (PR), stable disease (SD), progressive disease (PD) groups according to the therapeutic efficacy. Pearson correlation was used to analyze the correlation between different clinical variables and serum HIF-1α and VEGF levels before TACE, and correlation between serum HIF-1α and VEGF levels was also evaluated. 
Results The expression levels of serum HIF-1α and VEGF in PLC patients were 154.94±83.29 and 264.00±148.10 pg/mL pre-TACE, and both of them were significantly higher than those in control group (23.84±8.15 and 69.78±21.42 pg/mL, all P<0.01). One day after TACE, both serum HIF-1α (570.64± 230.87 pg/mL) and VEGF levels (362.07±102.25 pg/mL) reached the peak values (all P<0.01). One week post-TACE, expression levels of them were decreased (198.62±92.11 and 283.52±145.46 pg/mL respectively), but still significantly higher than those before TACE (all P<0.01). The levels of both HIF-1α (133.96±57.02 vs. 255.74±123.44 pg/mL) and VEGF (150.96±84.89 vs. 368.95±161.90 pg/mL) in CR group 1 month post-TACE were significantly lower than those in PR+SD+PD group (all P<0.01). The level of serum HIF-1α was positively correlated with serum VEGF level (r=0.42, P<0.001). Both serum HIF-1α and VEGF levels were observed to be correlated with portal vein tumor thrombi (P<0.05) and metastasis (P<0.05). 
Conclusion The HIF-1α and VEGF might play an important role in relapse of PLC. They might be considered as predictors of the efficacy of TACE and metastasis of PLC.

Key words: liver neoplasms, transcatheter arterial chemoembolization, hypoxia inducible factor 1 alpha, vascular endothelial growth factor

Copyright © 2021 Chinese Academy of Medical Sciences.  京公安备110402430088  京ICP备06002729号-1  Powered by Magtech.

Supervised by National Health Commission of the People's Republic of China

9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China

Tel: 86-10-65105897  Fax:86-10-65133074 


Copyright © 2018 Chinese Academy of Medical Sciences

All right reserved.

京公安备110402430088  京ICP备06002729号-1